series-c-plus
Stage
2
Investors
About
Avelo is a Zurich-based diagnostics startup developing a simple breath collector to enable non-invasive, painless sampling from the lower respiratory tract for diagnosing tuberculosis and other respiratory infections; collected samples are intended to be analyzed using existing PCR testing infrastructure.
Explore Avelo's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.